Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

February 2, 2015 Cover

Volume 93, Issue 5

FDA’s drug approvals in 2014 were remarkable for both their quantity and quality

Cover image:

Credit:

Full Article
Volume 93 | Issue 5

All Issues

Drug Development

The Year In New Drugs

FDA’s drug approvals in 2014 were remarkable for both their quantity and quality

  • Supercapacitor Makers Charge Ahead

    Materials research advances promise to make the energy storage device a complement to batteries

  • The Underlying Costs Of Research

    Reimbursements for the overhead costs of facilities and administrative support for grant-funded inquiry are controversial and often misunderstood

  • SK Is Ready For A New Round Of Purchases

    Private equity firm SK is scaling up its buy-and-hold strategy

ADVERTISEMENT
image name
Materials

Graphene’s Insolubility Drives Materials Synthesis

Method exploits pristine graphene’s knack for stabilizing interface between immiscible liquids

ADVERTISEMENT
ADVERTISEMENT